Wolfhart Kreuz
Department of Haematology
Johann-Wolfgang-Goethe-University Hospital
Centre of Paediatrics III
Frankfurt am Main
Germany
Name/email consistency: high
- C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis. Kreuz, W., Martinez-Saguer, I., Aygören-Pürsün, E., Rusicke, E., Heller, C., Klingebiel, T. Transfusion (2009)
- The role of VWF for the success of immune tolerance induction. Kreuz, W. Thromb. Res. (2008)
- Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A: results of an international clinical investigation. Kreuz, W., Gill, J.C., Rothschild, C., Manco-Johnson, M.J., Lusher, J.M., Kellermann, E., Gorina, E., Larson, P.J. Thromb. Haemost. (2005)









